Mosaic HIV-1 Vaccine Induces Responses in Humans, Monkeys

THURSDAY, July 12, 2018 -- A mosaic adenovirus serotype 26 (Ad26)-based HIV-1 vaccine induces immune responses in humans and rhesus monkeys, according to a study published online July 6 in The Lancet. Dan H. Barouch, M.D., from Harvard Medical...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news